{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:06:36Z","timestamp":1770750396366,"version":"3.50.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11845-024-03609-5","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T05:02:17Z","timestamp":1706158937000},"page":"1201-1207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-1443","authenticated-orcid":false,"given":"Ismail","family":"Demir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozden Yildirim","family":"Akan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda","family":"Bilgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giray","family":"Bozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oktay","family":"Bilgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"3609_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.738693","volume":"8","author":"W Cai","year":"2021","unstructured":"Cai W, Zeng Q, Zhang X et al (2021) Trends analysis of non-Hodgkin lymphoma at the national, regional, and global level, 1990\u20132019: results from the global burden of disease study 2019. Front Med 8:738693. https:\/\/doi.org\/10.3389\/fmed.2021.738693","journal-title":"Front Med"},{"issue":"10091","key":"3609_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA et al (2017) Non-Hodgkin lymphoma. Lancet (London, England) 390(10091):298\u2013310. https:\/\/doi.org\/10.1016\/S0140-6736(16)32407-2","journal-title":"Lancet (London, England)"},{"issue":"1","key":"3609_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medsci9010005","volume":"9","author":"KC Thandra","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K et al (2021) Epidemiology of non-Hodgkin\u2019s lymphoma. Med Sci (Basel, Switzerland) 9(1):5. https:\/\/doi.org\/10.3390\/medsci9010005","journal-title":"Med Sci (Basel, Switzerland)"},{"issue":"1","key":"3609_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","volume":"84","author":"AM M\u00fcller","year":"2005","unstructured":"M\u00fcller AM, Ihorst G, Mertelsmann R et al (2005) Epidemiology of non-Hodgkin\u2019s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84(1):1\u201312. https:\/\/doi.org\/10.1007\/s00277-004-0939-7","journal-title":"Ann Hematol"},{"issue":"3","key":"3609_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/path.2711","volume":"221","author":"D Aldinucci","year":"2010","unstructured":"Aldinucci D, Gloghini A, Pinto A et al (2010) The classical Hodgkin\u2019s lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol 221(3):248\u2013263. https:\/\/doi.org\/10.1002\/path.2711","journal-title":"J Pathol"},{"key":"3609_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/bj3260069","volume":"326","author":"H Toyoda","year":"1997","unstructured":"Toyoda H, Komurasaki T, Uchida D et al (1997) Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 326:69\u201375. https:\/\/doi.org\/10.1042\/bj3260069","journal-title":"Biochem J"},{"issue":"8","key":"3609_CR7","first-page":"1743","volume":"63","author":"C Lindvall","year":"2003","unstructured":"Lindvall C, Hou M, Komurasaki T et al (2003) Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res 63(8):1743\u20131747","journal-title":"Cancer Res"},{"issue":"2","key":"3609_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.mce.2010.04.008","volume":"331","author":"C Liebmann","year":"2011","unstructured":"Liebmann C (2011) EGF receptor activation by GPCRs: an universal pathway reveals different versions. Mol Cell Endocrinol 331(2):222\u2013231. https:\/\/doi.org\/10.1016\/j.mce.2010.04.008","journal-title":"Mol Cell Endocrinol"},{"key":"3609_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcdb.2014.03.005","volume":"28","author":"DJ Riese 2nd","year":"2014","unstructured":"Riese DJ 2nd, Cullum RL (2014) Epiregulin: roles in normal physiology and cancer. Semin Cell Dev Biol 28:49\u201356. https:\/\/doi.org\/10.1016\/j.semcdb.2014.03.005","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"3609_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mc.22475","volume":"56","author":"AK Bauer","year":"2017","unstructured":"Bauer AK, Velmurugan K, Xiong KN et al (2017) Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model. Mol Carcinog 56(1):94\u2013105. https:\/\/doi.org\/10.1002\/mc.22475","journal-title":"Mol Carcinog"},{"issue":"1","key":"3609_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J et al (2022) Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom 91(1):8\u201335. https:\/\/doi.org\/10.1159\/000521288","journal-title":"Psychother Psychosom"},{"issue":"3","key":"3609_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jcp.21635","volume":"218","author":"MR Schneider","year":"2009","unstructured":"Schneider MR, Wolf E (2009) The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218(3):460\u2013466. https:\/\/doi.org\/10.1002\/jcp.21635","journal-title":"J Cell Physiol"},{"issue":"1","key":"3609_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10549-009-0536-5","volume":"122","author":"E McIntyre","year":"2010","unstructured":"McIntyre E, Blackburn E, Brown PJ et al (2010) The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. Breast Cancer Res Treat 122(1):105\u2013110. https:\/\/doi.org\/10.1007\/s10549-009-0536-5","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3609_CR14","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1073\/pnas.0912710107","volume":"107","author":"T Hayashida","year":"2010","unstructured":"Hayashida T, Takahashi F, Chiba N et al (2010) HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci USA 107(3):1100\u20131105. https:\/\/doi.org\/10.1073\/pnas.0912710107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3609_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.canlet.2008.12.017","volume":"278","author":"T Kometani","year":"2009","unstructured":"Kometani T, Yoshino I, Miura N et al (2009) Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway. Cancer Lett 278(1):27\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2008.12.017","journal-title":"Cancer Lett"},{"issue":"3","key":"3609_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1158\/1940-6207.CAPR-08-0014","volume":"1","author":"J Zhang","year":"2008","unstructured":"Zhang J, Iwanaga K, Choi KC et al (2008) Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells. Cancer Prev Res\u00a0 (Philadelphia, Pa.) 1(3):201\u2013207. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-08-0014","journal-title":"Cancer Prev Res\u00a0 (Philadelphia, Pa.)"},{"issue":"3","key":"3609_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/ijc.31892","volume":"144","author":"F Bormann","year":"2019","unstructured":"Bormann F, Stinzing S, Tierling S et al (2019) Epigenetic regulation of amphiregulin and epiregulin in colorectal cancer. Int J Cancer 144(3):569\u2013581. https:\/\/doi.org\/10.1002\/ijc.31892","journal-title":"Int J Cancer"},{"issue":"45","key":"3609_CR18","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1038\/s41388-022-02476-7","volume":"41","author":"C Wang","year":"2022","unstructured":"Wang C, Long Q, Fu Q et al (2022) Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance. Oncogene 41(45):4941\u20134959. https:\/\/doi.org\/10.1038\/s41388-022-02476-7","journal-title":"Oncogene"},{"issue":"3","key":"3609_CR19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4049\/jimmunol.1400562","volume":"194","author":"D Kamimura","year":"2015","unstructured":"Kamimura D, Arima Y, Kohsaka H et al (2015) Temporal expression of growth factors triggered by epiregulin regulates inflammation development. J Immunol 194(3):1039\u20131046. https:\/\/doi.org\/10.4049\/jimmunol.1400562","journal-title":"J Immunol"},{"issue":"2","key":"3609_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/1097-0142(19800115)45:2<318::aid-cncr2820450220>3.0.co;2-c","volume":"45","author":"JA Child","year":"1980","unstructured":"Child JA, Spati B, Illingworth S et al (1980) Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patients. Cancer 45(2):318\u2013326. https:\/\/doi.org\/10.1002\/1097-0142(19800115)45:2%3c318::aid-cncr2820450220%3e3.0.co;2-c","journal-title":"Cancer"},{"issue":"1","key":"3609_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000362670","volume":"87","author":"L Wu","year":"2014","unstructured":"Wu L, Wang T, Gui W et al (2014) Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma. Oncology 87(1):40\u201347. https:\/\/doi.org\/10.1159\/000362670","journal-title":"Oncology"},{"issue":"4","key":"3609_CR22","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1073\/pnas.96.4.1633","volume":"96","author":"DS Taylor","year":"1999","unstructured":"Taylor DS, Cheng X, Pawlowski JE et al (1999) Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin. Proc Natl Acad Sci USA 96(4):1633\u20131638. https:\/\/doi.org\/10.1073\/pnas.96.4.1633","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03609-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03609-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03609-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T02:31:53Z","timestamp":1716777113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03609-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["3609"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03609-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"3 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the institutional review board for exemption.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}